Literature DB >> 18185985

A novel design of artificial membrane for improving the PAMPA model.

Xiaoxi Chen1, Anthony Murawski, Karishma Patel, Charles L Crespi, Praveen V Balimane.   

Abstract

PURPOSE: Since the first demonstration of PAMPA, the artificial membrane has been traditionally prepared by impregnating a porous filter with a solution of lipid mixture. While the lipid solution-based method is simple and seems to provide good predictability for many compounds, it is challenged by several shortcomings including reproducibility, stability, mass retention and the incorrect prediction of a group of highly permeable compounds including caffeine and antipyrine. Here we present the validation of a novel artificial membrane formed by constructing a lipid/oil/lipid tri-layer in the porous filter.
METHODS: Permeability values obtained from traditional and new artificial membrane were compared for their correlation with Caco-2 and human absorption values. Mass retention, stability and organic solvent compatibility of the new artificial membrane were studied.
RESULTS: The new artificial membrane correctly predicts the permeability of the traditionally under-predicted compounds and improves the correlation with Caco-2 and human absorption values. Furthermore, the new artificial membrane reduces the mass retention of compounds that are highly retained by the traditional artificial membrane. The new artificial membrane is also found to be robust enough to sustain long term storage and has good compatibility with organic solvents.
CONCLUSIONS: The new artificial membrane provides an improved PAMPA model.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18185985     DOI: 10.1007/s11095-007-9517-8

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  19 in total

1.  In vitro permeability of poorly aqueous soluble compounds using different solubilizers in the PAMPA assay with liquid chromatography/mass spectrometry detection.

Authors:  Hanlan Liu; Chantel Sabus; Guy T Carter; Chao Du; Alex Avdeef; Mark Tischler
Journal:  Pharm Res       Date:  2003-11       Impact factor: 4.200

2.  Development of a 7-day, 96-well Caco-2 permeability assay with high-throughput direct UV compound analysis.

Authors:  Jochem Alsenz; E Haenel
Journal:  Pharm Res       Date:  2003-12       Impact factor: 4.200

Review 3.  Cell culture-based models for intestinal permeability: a critique.

Authors:  Praveen V Balimane; Saeho Chong
Journal:  Drug Discov Today       Date:  2005-03-01       Impact factor: 7.851

4.  Caco-2 permeability of weakly basic drugs predicted with the double-sink PAMPA pKa(flux) method.

Authors:  Alex Avdeef; Per Artursson; Sibylle Neuhoff; Lucia Lazorova; Johan Gråsjö; Staffan Tavelin
Journal:  Eur J Pharm Sci       Date:  2005-01-20       Impact factor: 4.384

5.  A novel high-throughput automated chip-based nanoelectrospray tandem mass spectrometric method for PAMPA sample analysis.

Authors:  Praveen V Balimane; Ellen Pace; Saeho Chong; Mingshe Zhu; Mohammed Jemal; Colleen K Van Pelt
Journal:  J Pharm Biomed Anal       Date:  2005-09-01       Impact factor: 3.935

Review 6.  Current industrial practices of assessing permeability and P-glycoprotein interaction.

Authors:  Praveen V Balimane; Yong-Hae Han; Saeho Chong
Journal:  AAPS J       Date:  2006-01-13       Impact factor: 4.009

Review 7.  Intestinal drug absorption and metabolism in cell cultures: Caco-2 and beyond.

Authors:  P Artursson; R T Borchardt
Journal:  Pharm Res       Date:  1997-12       Impact factor: 4.200

8.  High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes.

Authors:  F Wohnsland; B Faller
Journal:  J Med Chem       Date:  2001-03-15       Impact factor: 7.446

9.  Drug absorption in vitro model: filter-immobilized artificial membranes. 2. Studies of the permeability properties of lactones in Piper methysticum Forst.

Authors:  A Avdeef; M Strafford; E Block; M P Balogh; W Chambliss; I Khan
Journal:  Eur J Pharm Sci       Date:  2001-12       Impact factor: 4.384

10.  High throughput artificial membrane permeability assay for blood-brain barrier.

Authors:  Li Di; Edward H Kerns; Kristi Fan; Oliver J McConnell; Guy T Carter
Journal:  Eur J Med Chem       Date:  2003-03       Impact factor: 6.514

View more
  43 in total

1.  Synthesis and anticholinesterase activity of novel non-hepatotoxic naphthyridine-11-amine derivatives.

Authors:  Belma Zengin Kurt
Journal:  Mol Divers       Date:  2018-12-04       Impact factor: 2.943

Review 2.  Coexistence of passive and carrier-mediated processes in drug transport.

Authors:  Kiyohiko Sugano; Manfred Kansy; Per Artursson; Alex Avdeef; Stefanie Bendels; Li Di; Gerhard F Ecker; Bernard Faller; Holger Fischer; Grégori Gerebtzoff; Hans Lennernaes; Frank Senner
Journal:  Nat Rev Drug Discov       Date:  2010-08       Impact factor: 84.694

3.  Confocal imaging to quantify passive transport across biomimetic lipid membranes.

Authors:  Su Li; Peichi Hu; Noah Malmstadt
Journal:  Anal Chem       Date:  2010-09-15       Impact factor: 6.986

4.  Imaging molecular transport across lipid bilayers.

Authors:  Su Li; Peichi C Hu; Noah Malmstadt
Journal:  Biophys J       Date:  2011-08-03       Impact factor: 4.033

5.  Predicting the extent of metabolism using in vitro permeability rate measurements and in silico permeability rate predictions.

Authors:  Chelsea M Hosey; Leslie Z Benet
Journal:  Mol Pharm       Date:  2015-04-23       Impact factor: 4.939

6.  In situ artificial membrane permeation assay under hydrodynamic control: permeability-pH profiles of warfarin and verapamil.

Authors:  Matej Velický; Dan F Bradley; Kin Y Tam; Robert A W Dryfe
Journal:  Pharm Res       Date:  2010-05-07       Impact factor: 4.200

7.  Pharmacokinetic evaluation and in vitro-in vivo correlation (IVIVC) of novel methylene-substituted 3,3' diindolylmethane (DIM).

Authors:  Apurva R Patel; Shawn D Spencer; Mahavir B Chougule; Stephen Safe; Mandip Singh
Journal:  Eur J Pharm Sci       Date:  2012-02-08       Impact factor: 4.384

8.  Development of dual casein kinase 1δ/1ε (CK1δ/ε) inhibitors for treatment of breast cancer.

Authors:  Andrii Monastyrskyi; Napon Nilchan; Victor Quereda; Yoshihiko Noguchi; Claudia Ruiz; Wayne Grant; Michael Cameron; Derek Duckett; William Roush
Journal:  Bioorg Med Chem       Date:  2017-12-15       Impact factor: 3.641

9.  Oral delivery of ionic complex of ceftriaxone with bile acid derivative in non-human primates.

Authors:  Ok-Cheol Jeon; Seung Rim Hwang; Taslim A Al-Hilal; Jin Woo Park; Hyun Tae Moon; Seulki Lee; Jae Hyung Park; Youngro Byun
Journal:  Pharm Res       Date:  2013-01-05       Impact factor: 4.200

10.  Structure-Activity Relationship Study on Odoamide: Insights into the Bioactivities of Aurilide-Family Hybrid Peptide-Polyketides.

Authors:  Masato Kaneda; Shinsaku Kawaguchi; Nobutaka Fujii; Hiroaki Ohno; Shinya Oishi
Journal:  ACS Med Chem Lett       Date:  2018-03-05       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.